Omega-3 Fatty Acids Recommended for Hypertriglyceridemia; Dapagliflozin Effective in HF; Plant‐Based Diets Linked to Lower CVD Risk
A science advisory from the American Heart Association recommended that prescription n-3 fatty acids (eicosapentaenoic acid [EPA]+docosahexaenoic acid [DHA] or EPA-only) at a dose of 4 g/d (>3 g/d total EPA+DHA) are an effective and safe option for reducing triglycerides as monotherapy or as an adjunct to other lipid-lowering agents […]